logo IDIBELL
Català  |   Castellano  |   English
Search
The InstituteResearchWhat's onPlatformsJoin usTools
 

News


 
23/01/2018

La ONCE y el IDIBELL avanzan en estudios genéticos para prevenir las distrofias de retina

foto 1048

Las distrofias hereditarias de la retina son desórdenes con gran heterogeneidad clínica y genética para los que no hay cura a día de hoy y que afectan 15000 personas en España

More information

 
 
18/01/2018

Researchers identify a new NF-kB pathway regulatory mechanism linked to SirT6

foto 1047

More information

 
 
16/01/2018

Conxi Lázaro, Juani Fernández and Alberto Villanueva receive an NF Research Initiative grant to test combination therapies in MPNST

foto 1045

More information

 
 
11/01/2018

IDIBELL researchers successfully test a new combination therapy in sarcomas

foto 1046

More information

 
1 2 3 4 5 
 
© 2018 Institut d'Investigació Biomèdica de Bellvitge



Results by pageInitial date
Select date
TitleFinal date
Select date
Search


Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications

New password:
Confirm new password:

Accept



Your password is about to expire. Please, write in a new password to continue

Remember this password allows you to access to all IDIBELL’s web applications

New password:
Confirm new password:

Accept


Cancell

Passwords doesn’t match
The password must have at least 6 characters
The new password can not contain special characters
User register

Name
Surname
Second Surname
E-mail
User
Password
Language


Accept


Cancell




Encara no heu contestat l'enquesta de satisfacció sobre la píndola formativa sobre patents. No trigareu més de cinc minuts a fer-ho. La vostra opinió és molt important per millorar l’IDIBELL.

Voleu fer l’enquesta ara?

Yes

No




Further personal and contact information is needed to maintain IDIBELL databases.

Do you wish to fill the form now?

Yes

No





Please, remember to introduce your holiday’s planning in the application

Accept

Cancell